Network origin in Chris Stevens first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA.
2
| Extinct | Biotechnology | 2 |
| Public Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chris Stevens via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Corporate Officer/Principal | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder | |
Arbor Pharmaceuticals LLC
 Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | President | |
Aptalis Pharma US, Inc.
 Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. The firm also provides products for active ulcerative, liver diseases, pancreatic diseases, cystic fibrosis, chronic obstructive pulmonary disease, HIV/AIDS and cancer. The company was founded in 1991 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Sales & Marketing | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Investment Committee Member | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Rice University | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Stonehill College, Inc. | College/University | Undergraduate Degree | |
| Metropolitan State University of Denver | College/University | Undergraduate Degree | |
| Franklin & Marshall College | College/University | Undergraduate Degree | |
| University of Maine | College/University | Undergraduate Degree | |
| Baylor College of Medicine | College/University | Doctorate Degree | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Sales & Marketing | |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Moscow University | College/University | Doctorate Degree | |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Medical Specialties | Director/Board Member | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal | |
| R.W. Johnson Pharmaceutical Research Institute | Corporate Officer/Principal | ||
| Sage BioPharma, Inc. | Sales & Marketing | ||
| EPIZYME, INC. | Biotechnology | Director/Board Member | |
| USA Volleyball | Director/Board Member | ||
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Other | Founder Founder Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Penn State Hershey College of Medicine | College/University | Doctorate Degree | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BEFORE Brands, Inc.
 BEFORE Brands, Inc. Food: Specialty/CandyConsumer Non-Durables BEFORE Brands, Inc. engages in the provision of pediatric nutritional products. It offers the SpoonfulOne, a line of childhood nutritional products designed to reduce food allergy development risk with key allergens. The company was founded by Ashley Ledbetter Dombkowski and Kari Nadeau in 2015 and is headquartered in Menlo Park, CA. | Food: Specialty/Candy | Chief Executive Officer | |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder | |
| HUDSON EXECUTIVE INVESTMENT CORP. III | Financial Conglomerates | Director/Board Member | |
Anagram Therapeutics, Inc.
 Anagram Therapeutics, Inc. Medical/Nursing ServicesHealth Services Anagram Therapeutics, Inc. provides healthcare services. The company is based in Framingham, MA. The CEO of the company is Robert Gallotto. | Medical/Nursing Services | Chairman Chief Executive Officer | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 49 |
| Japan | 2 |
| Russia | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 10 |
| Finance | 6 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 29 |
| Corporate Officer/Principal | 20 |
| Chief Tech/Sci/R&D Officer | 11 |
| President | 11 |
| Independent Dir/Board Member | 10 |
Most connected contacts
| Insiders | |
|---|---|
| Ashley L. Dombkowski | 17 |
| David McGirr | 16 |
| Lee R. Brettman | 11 |
| Robert Gallotto | 10 |
| Hugh Wight | 9 |
| Thomas Rowland | 8 |
| Chip Clark | 7 |
| Christopher Morabito | 7 |
| Alexey L. Margolin | 6 |
- Stock Market
- Insiders
- Chris Stevens
- Company connections
